Ruxolitinib Impurity 38 | CAS 1236033-37-6 - Request Quote
Ruxolitinib Impurity 38
| SZ CAT No: | SZ-R044064 |
| CAS No | 1236033-37-6 |
| Mol.F. | C8H11N |
| Mol.Wt. | 121.2 |
| Inv. Status | Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Ruxolitinib Impurity 38 is chemically (E)-3-cyclopentylacrylonitrile. Ruxolitinib Impurity 38 is supplied with detailed characterization data compliant with regulatory guideline. Ruxolitinib Impurity 38 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Ruxolitinib.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 1236033-37-6
Purchase 1236033-37-6
Order 1236033-37-6
Enquire 1236033-37-6
price of 1236033-37-6
1236033-37-6 Supplier
1236033-37-6 Manufacturer
1236033-37-6 Exporter
buy high quality Ruxolitinib Impurity 38
Purchase Ruxolitinib Impurity 38
Ruxolitinib Impurity 38 suppliers
Ruxolitinib Impurity 38 manufacturers
Ruxolitinib Impurity 38 price
Order Ruxolitinib Impurity 38
Enquire Ruxolitinib Impurity 38
Ruxolitinib Impurity 38 cost
Ruxolitinib Impurity 38 Supplier
Ruxolitinib Impurity 38 Distributor
Ruxolitinib Impurity 38 for Method Validation
Ruxolitinib Reference Standard
Ruxolitinib Impurity 38 for ANDA Filing
Ruxolitinib Impurity 38 for Forced Degradation Studies
Ruxolitinib Impurity 38 Identification Standards
Ruxolitinib Impurity 38 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.


